New York officials may have found an answer for the mysterious rash of illnesses linked to vaping that has already claimed three lives in the United States. On Thursday, the state’s Department of Health announced that it had uncovered lab results that identified “very high levels” of vitamin E acetate in “nearly all” the cannabis products they had examined in relationship to the vaping illness. Authorities say vitamin E is now “a key focus” of the investigation going forward.
“It is really starting to look like this is a cannabis vaping issue and that it may not have anything to do with e-cigarettes,” Michael Siegel of Boston University, who is a tobacco expert and public health professor, told USA Today.
Across the county, over 215 vape users have been hospitalized for breathing problems, and there have been three reported deaths to date, one in Oregon, one in Illinois, and one in Indiana. The condition has often been misdiagnosed as pneumonia, and patients have complained of cough, shortness of breath, chest pain, fatigue, fever and gastrointestinal distress such as nausea, abdominal pain, and diarrhea, among other symptoms. In New York, those who had been hit with the lung condition were mainly between the ages of 17 and 30.
New York Department of Health officials said that vitamin E acetate had been identified in each sample of cannabis products submitted by affected individuals. The Food and Drug Administration had also identified vitamin E oil in many samples submitted by patients.
“No one substance, including vitamin E acetate, has been identified in all of the samples tested,” said FDA spokesperson Michael Felberbaum to CBS News. “Importantly, identifying any compounds that are present in the samples will be